• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ann Transl Med . Association between sore throat and early immune responses against COVID-19 before and after the emergence of the Omicron variant

tetano

Editor, Senior Moderator
Ann Transl Med


. 2024 Oct 20;12(5):87.
doi: 10.21037/atm-24-36. Epub 2024 Sep 19. Association between sore throat and early immune responses against COVID-19 before and after the emergence of the Omicron variant

Yusuke Takegoshi[SUP] 1 [/SUP], Kentaro Nagaoka[SUP] 1 2 [/SUP], Toshiki Kido[SUP] 3 [/SUP], Hitoshi Kawasuji[SUP] 1 [/SUP], Yushi Murai[SUP] 1 [/SUP], Makito Kaneda[SUP] 1 [/SUP], Kou Kimoto[SUP] 1 [/SUP], Hideki Tani[SUP] 4 [/SUP], Hideki Niimi[SUP] 2 5 6 [/SUP], Yoshitomo Morinaga[SUP] 2 6 7 [/SUP], Yoshihiro Yamamoto[SUP] 1 2 6 [/SUP]



Affiliations
Abstract

Background: Sore throat is a prevalent symptom of coronavirus disease 2019 (COVID-19), particularly when caused by the Omicron variants. However, the association between sore throat and immune responses to different severe acute respiratory syndrome coronavirus 2 variants remains unclear. This study aimed to elucidate the characteristics of immune responses associated with sore throat in patients with COVID-19 before and after the emergence of Omicron.
Methods: In this prospective observational study, we enrolled patients with COVID-19 hospitalized between December 2020 and April 2022, which covered the pre-Omicron and Omicron (BA.1 variant) endemic periods. Sore throat was assessed using a daily questionnaire, including an analog scale for sore throat grade (0 to 3) from admission until discharge. Serum levels of immune indicators were assessed using enzyme-linked immunosorbent assay.
Results: A total of 47 patients infected with Omicron and 136 patients infected with preceding variants were included in the analyses. The frequency of sore throat was significantly higher in participants infected with Omicron than that in those infected with preceding variants (66% vs. 42%, P<0.005). Sore throat was associated with nasopharyngeal viral load, interleukin-6 (IL-6)/interferon-α (IFN-α) levels in participants infected with preceding variants, whereas, it was associated with age, the body mass index, and interferon-λ1 (IFN-λ1) in participants infected with Omicron.
Conclusions: Infection with the Omicron variant is characterized by increased sore throat frequency and altered associations between sore throat and several immune indicators, including IFN-α, IL-6, and IFN-λ1.

Keywords: Coronavirus disease 2019 (COVID-19); immune response; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); sore throat.

 
Back
Top Bottom